Stockscreener 앱 받기
6.09
16.44%
0.86
시간 외 거래:
6.15
0.06
+0.99%
전일 마감가:
$5.23
열려 있는:
$5.25
하루 거래량:
93.53M
Relative Volume:
3.45
시가총액:
$2.60B
수익:
$64.60M
순이익/손실:
$-377.75M
주가수익비율:
-3.929
EPS:
-1.55
순현금흐름:
$-335.64M
1주 성능:
+19.41%
1개월 성능:
+31.82%
6개월 성능:
+53.40%
1년 성능:
-5.43%
1일 변동 폭
$5.19
$6.30
1주일 범위
$5.11
$6.30
52주 변동 폭
$3.79
$12.36
리커젼 파마 Stock (RXRX) Company Profile
명칭
Recursion Pharmaceuticals Inc
전화
(385) 269-0203
주소
41S RIO GRANDE STREET, SALT LAKE CITY
RXRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RXRX
Recursion Pharmaceuticals Inc
|
6.09 | 2.28B | 64.60M | -377.75M | -335.64M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.15 | 105.19B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.68 | 60.24B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.86 | 61.82B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
798.94 | 49.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
351.09 | 37.52B | 4.56B | -176.77M | 225.30M | -1.7177 |
리커젼 파마 Stock (RXRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-03 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-05-22 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-03-16 | 개시 | Needham | Buy |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-04-18 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-03-04 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-09-21 | 개시 | Berenberg | Buy |
| 2021-05-11 | 개시 | BofA Securities | Buy |
| 2021-05-11 | 개시 | Goldman | Neutral |
| 2021-05-11 | 개시 | JP Morgan | Neutral |
| 2021-05-11 | 개시 | KeyBanc Capital Markets | Overweight |
| 2021-05-11 | 개시 | SVB Leerink | Outperform |
모두보기
리커젼 파마 주식(RXRX)의 최신 뉴스
What's Going On With Recursion Pharmaceuticals Stock On Wednesday? - Benzinga
Recursion Pharmaceuticals Shares Surge Amid Strategic Growth - TipRanks
AI Drug Discovery Darling? Recursion Pharma (RXRX) Stock’s Wild Ride in 2025 - ts2.tech
Recursion Pharmaceuticals, Inc. (RXRX): A Bull Case Theory - Yahoo Finance
Recursion Pharmaceuticals (RXRX) Dips More Than Broader Market: What You Should Know - Nasdaq
RXRX Shares Plunge: Time to Bail Out? - StocksToTrade
Needham Reiterates a Buy on Recursion Pharmaceuticals (RXRX) - MSN
Can Recursion Pharmaceuticals Inc. recover in the next quarterJuly 2025 Analyst Calls & Safe Capital Allocation Plans - newser.com
Custom strategy builders for tracking Recursion Pharmaceuticals Inc.2025 Trade Ideas & Weekly Watchlist for Hot Stocks - newser.com
How to recover losses in Recursion Pharmaceuticals Inc. stock2025 Market Sentiment & Verified Technical Trade Signals - newser.com
Is Recursion Pharmaceuticals Inc. still worth holding after the dip2025 Growth vs Value & Fast Exit Strategy with Risk Control - newser.com
Will Recursion Pharmaceuticals Inc. stock recover faster than market2025 Big Picture & Entry and Exit Point Strategies - newser.com
Should you wait for a breakout in Recursion Pharmaceuticals Inc.Trade Entry Summary & Real-Time Buy Zone Alerts - newser.com
Biotech Stocks To Watch NowOctober 4th - MarketBeat
Why Recursion Pharmaceuticals (RXRX) Is Up 19.2% After Securing $12.5M Milestone in AI Drug Partnership - simplywall.st
Biotech Stocks To ResearchOctober 3rd - MarketBeat
Recursion Pharmaceuticals (RXRX) Surges 8.2%: Is This an Indication of Further Gains? - Yahoo Finance
Evaluating Recursion After a 19% Rally Amid Renewed Interest in Biotech AI Initiatives - Yahoo Finance
Recursion Pharmaceuticals (RXRX): Assessing Valuation Following New Milestone Payment and Drug Development Progress - simplywall.st
Smart tools for monitoring Recursion Pharmaceuticals Inc.’s price actionWeekly Profit Summary & Weekly Momentum Picks - newser.com
Published on: 2025-10-03 01:30:40 - newser.com
Published on: 2025-10-02 22:53:16 - newser.com
Recursion Pharmaceuticals, Inc. (RXRX) Expands Rare Disease Pipeline with REV102 Acquisition - MSN
Best Biotech Stocks To Watch NowOctober 2nd - MarketBeat
Recursion Pharmaceuticals Inc. (RXRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
RXRX’s Market Moves: A Deep Dive - timothysykes.com
Recursion Pharmaceuticals’ Bold Strategy: A Gamechanger? - StocksToTrade
Recursion Pharmaceuticals Stock (RXRX) Opinions on $12.5M Milestone Payment - Quiver Quantitative
Published on: 2025-09-30 19:47:45 - newser.com
Jim Cramer on Recursion: “I Need to See a Proof of Concept Here” - MSN
Prediction: These 2 Under-the-Radar Stocks Could Beat the Market in the Next 5 Years - AOL.com
Recursion Pharmaceuticals’ Recent Moves: What’s Next? - timothysykes.com
Recursion Pharmaceuticals’ Unexpected Surge - StocksToTrade
Recursion’s New Moves: Market Shake-Up? - timothysykes.com
리커젼 파마 (RXRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.05%
4.71%
자본화:
|
볼륨(24시간):